Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 526 AL 540

Did the COVID-19 Pandemic Affect the Use of Antipsychotics Among Nursing Home Residents With ADRD?

Yan D, Temkin-Greener H, Cai S.

Am J Geriatr Psychiatry. 2023 Feb;31(2):124-140. doi: 10.1016/j.jagp.2022.09.009. Epub 2022 Sep 28.

Chronic pain in Alzheimer's disease: Endocannabinoid system

Blanton H, Reddy PH, Benamar K.

Exp Neurol. 2023 Feb;360:114287. doi: 10.1016/j.expneurol.2022.114287. Epub 2022 Nov 29.

Application of curcumin nanoformulations in Alzheimer's disease: prevention, diagnosis and treatment

Lv H, Wang Y, Yang X, Ling G, Zhang P.

Nutr Neurosci. 2023 Aug;26(8):727-742. doi: 10.1080/1028415X.2022.2084550. Epub 2022 Jun 11.

Amyloid-Related Imaging Abnormalities: An Update

Roytman M, Mashriqi F, Al-Tawil K, Schulz PE, Zaharchuk G, Benzinger TLS, Franceschi AM.

AJR Am J Roentgenol. 2023 Apr;220(4):562-574. doi: 10.2214/AJR.22.28461. Epub 2022 Nov 2.

Effects of physical activity and exercise interventions on Alzheimer's disease: an umbrella review of existing meta-analyses

López-Ortiz S, Lista S, Valenzuela PL, Pinto-Fraga J, Carmona R, Caraci F, Caruso G, Toschi N, Emanuele E, Gabelle A, Nisticò R, Garaci F, Lucia A, Santos-Lozano A.

J Neurol. 2023 Feb;270(2):711-725. doi: 10.1007/s00415-022-11454-8. Epub 2022 Nov 7.

Lecanemab in Early Alzheimer's Disease

van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T.

N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.

Challenges in the pharmacological treatment of patients under suspicion of chronic traumatic encephalopathy: A review

Roberta de Souza Mendes Kawamura L, Ferreira Lima Mota I, Santos Vasconcelos A, Renata Mortari M.

Brain Res. 2023 Jan 15;1799:148176. doi: 10.1016/j.brainres.2022.148176. Epub 2022 Nov 26.

Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer's disease: relevance for precision medicine in neurodegenerative diseases

Lista S, Vergallo A, Teipel SJ, Lemercier P, Giorgi FS, Gabelle A, Garaci F, Mercuri NB, Babiloni C, Gaire BP, Koronyo Y, Koronyo-Hamaoui M, Hampel H, Nisticò R; Neurodegeneration Precision Medicine Initiative (NPMI).

Ageing Res Rev. 2023 Feb;84:101819. doi: 10.1016/j.arr.2022.101819. Epub 2022 Dec 13.

Pharmacologic treatment of depression in Alzheimer's disease

Haussmann R, Donix M.

Int Clin Psychopharmacol. 2023 Mar 1;38(2):81-88. doi: 10.1097/YIC.0000000000000439. Epub 2022 Nov 10.

CDiP technology for reverse engineering of sporadic Alzheimer's disease

Kondo T, Yada Y, Ikeuchi T, Inoue H.

J Hum Genet. 2023 Mar;68(3):231-235. doi: 10.1038/s10038-022-01047-8. Epub 2022 Jun 10.

The role of genetic risk factors of Alzheimer's disease in synaptic dysfunction

Fu WY, Ip NY.

Semin Cell Dev Biol. 2023 Apr;139:3-12. doi: 10.1016/j.semcdb.2022.07.011. Epub 2022 Jul 30.

Meta-analysis of clinical efficacy and safety of yangxuenao granules combined with cholinesterase inhibitors in the treatment of vascular cognitive impairment

Peng C, Zhou D.

Minerva Med. 2023 Jun;114(3):399-401. doi: 10.23736/S0026-4806.22.08339-2. Epub 2022 Sep 30.

The effects of synthetic glucocorticoid treatment for inflammatory disease on brain structure, function, and dementia outcomes: A systematic review

Shorey CL, Mulla RT, Mielke JG.

Brain Res. 2023 Jan 1;1798:148157. doi: 10.1016/j.brainres.2022.148157. Epub 2022 Nov 8.

Therapeutics for mitochondrial dysfunction-linked diseases in Down syndrome

Ganguly BB, Kadam NN.

Mitochondrion. 2023 Jan;68:25-43. doi: 10.1016/j.mito.2022.11.003. Epub 2022 Nov 9.

Treatment of Vascular and Neurodegenerative Forms of Cognitive Impairment and Dementias

Perlett L, Smith EE.

Clin Geriatr Med. 2023 Feb;39(1):135-149. doi: 10.1016/j.cger.2022.07.008. Epub 2022 Oct 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias